Viewing nowLipistop 20 mg Tablet (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

MFDS item code 200808409 · Notified 2008.08.05 · Insurance code 642902850
Improvement of hyperlipidemia (including familial hypercholesterolemia in children) and prevention of cardiovascular disease (such as myocardial infarction)
This medication helps reduce the risk of cardiovascular diseases. It specifically lowers the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. It also reduces the risk of hospitalization due to unstable angina, the need for vascular reconstruction, and congestive heart failure. In patients with hyperlipidemia, it effectively reduces total cholesterol and LDL cholesterol levels while increasing HDL cholesterol levels, serving as an adjunct to dietary therapy. It also helps lower cholesterol levels in patients with heterozygous familial hypercholesterolemia, aiding in the management of cardiovascular disease risk. In summary, this medication is effectively used to reduce the risk of cardiovascular diseases and improve dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is only for patients who require a reduction in LDL cholesterol of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the aim of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on administering doses of this medicine higher than 20 mg in pediatric patients.). The dose should be adjusted appropriately in each patient according to the recommended treatment goals. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms, so you must inform your doctor immediately if you experience severe muscle pain or weakness. Especially, if there is a significant increase in muscle enzyme levels or if severe myopathy is suspected, the medication should be discontinued. Additionally, caution should be exercised, or the medication temporarily stopped, in cases of acute infection, severe trauma, liver disease, and other specific conditions. This medication can affect liver function, so it should not be administered to patients with liver disease or elevated liver enzyme levels, and liver function tests should be performed regularly during treatment. It is not used in pregnant women or women who may become pregnant, nursing mothers, and children under 10 years of age. Special caution should be taken when administering the medication to individuals with a history of alcoholism or liver disease, elderly patients, and patients with impaired kidney function. This medication may interact with other drugs, so consultation with a doctor is necessary, especially when used concurrently with certain antibiotics, antifungals, antivirals, and some hyperlipidemia treatments. Consumption of grapefruit juice should be avoided as it may increase the blood concentration of this medication, raising the risk of side effects. During treatment, appropriate contraception is necessary, and the medication should be discontinued immediately upon confirmation of pregnancy. If you experience symptoms such as muscle pain, fatigue, or fever, notify medical staff immediately and undergo necessary tests. Keep out of reach of children and store in the original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This helps to maintain the drug's efficacy and prevent deterioration.
White round film-coated tablet
For domestic use (30 tablets) - 10 tablets/PTP, For domestic use (30 tablets) - 3 PTP/box, For domestic use (100 tablets) - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.